Novartis AG (NYSE:NVS) Given Price Target Of $92.75


As per Novartis AG (NYSE:NVS)’s news release on 2016-04-11, its shareholders will get cash dividend of $2.303 per share. The recent press release updated on the record date and payout date, which stands at 2016-02-26 and 2016-04-15, respectively.

The stock will commence trading ex-dividend from 2016-02-24, until, which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year Novartis AG (NYSE:NVS) disbursed $2.303 in dividend compared to distribution of $2.303, a year ago.

It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of 25.9045%.

Analyst Perspective

The sell-side market professionals who track the firm’s financial and technical parameters have estimated Novartis AG (NYSE:NVS) to attain a price target of $92.75. It is an average estimate figure given by 4 analysts tracking the stock. The estimates disclosed that the stock can move up on the chart and hit a high of $115. The low price range is set at $84 for next year while the arithmetic mean is seen at 2.41.

Eyeing Earnings Novartis AG (NYSE:NVS) is likely to post quarterly numbers around 2016-10-25 for the quarter ending 2016-09-30. The quarterly EPS projection is set at $1.19 for the period ending on 2016-09-30.

In last quarter ended 2015-12-31, Novartis AG (NYSE:NVS) earnings came at $1.22 suggesting a deviation of $0.04. The brokerages targeted EPS of $1.18 for the quarter.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)